Abstract: The present invention relates to the use of selected polypeptides from African Swine virus for the prevention and therapy of African Swine infections as well as other infections, including immune deficiencies in mammals and humans.

Abstract: The description discloses a method of producing therapeutic peptides as vaccines in the prevention of human diseases that are caused by one or more proteins. The method comprises identifying the protein responsible for causing the human disease; identifying one or more signal oligopeptide sequences within the structure of the disease causing protein, the one or more signal oligopeptides representing the amino acid sequence of maximum hydrophilicity; and synthesizing one or more vaccine oligopeptides, the vaccine oligopeptides having amino acid sequences corresponding to the amino acid sequences of the signal oligopeptides of maximum hydrophilicity.

Abstract: The present invention provides for a stent for treatment and prevention of arterial stenosis and re-stenosis. The stent for intraluminal placement within an artery and subsequent expansion for implantation in a patient comprises of a main body portion having a first end and a second end, for defining a passage for flow of blood there-through, the main body portion having an inner lumen surface and an outer lumen surface, the outer lumen surface coming into contact with the endothelium and delivering a drug composition on the outer lumen surface directly only to the endothelium for providing cell surface antithrombotic activity, wherein the anticoagulation activity in the blood plasma of a patient is not appreciably increased.

Abstract: The present invention provides for a method of using a nutritional composition in inhibiting smooth muscle cell contraction, and hence lowering hypertension.

Abstract: A composition of biochemical substances for the treatment of arrhythmia in a human susceptible to arrhythmia, and its method of administration, comprising at least one ascorbate compound selected from the group consisting of ascorbic acid, pharmaceutically acceptable ascorbate salts and/or mixtures thereof in combination with at least one carnitine compound selected from the group of carnitine hydrochloride, pharmaceutically acceptable carnitine salts and/or mixtures thereof.

Abstract: The present invention provides for a method for treatment and prevention of Type II Diabetes Mellitus and its complications comprising the step of administering to a patient a therapeutically-effective amount of Rhamnan Sulphate, its functional analogs, or its physiologically acceptable salts, in therapeutic proportions. Anticoagulation activity in the blood plasma of a patient is not appreciably increased.

Abstract: A device and method is disclosed for creating at least two pockets in a keycard holder comprising the steps of, cutting a piece of paper across one length at an angle between 20 and 30 degrees to the width, such that the width is approximately 6 inches on one side and the length is approximately between 5.5 and 6.5 inches on one side, folding the said paper in half across its length, folding the right and left edges of the width along the length in to meet at a midline, folding the left side over the right side along the midline to make a rectangle of approximately 2 ¾ by 4 ¼ inches, to create a first and second pocket.